Health
Therapeutic PD-1 cancer vaccine shown to be safe and effective in animal study: First-in-human clinical trial will test vaccine in select cancer patients – Science Daily
A study has described a potential therapeutic anticancer vaccine that frees suppressed cancer-killing immune cells, enabling them to attack and destroy a tumor.
A study led by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) described a potential therapeutic anticancer vaccine that frees suppressed cancer-killing immune cells, enabling them to attack and destroy a tumor.Published in the journal Oncoimmunology, on October 1, 2020, the findings showed that the peptide called PD1-Vaxx, a first checkpoint inhibitor vaccine, was safe and effective…
-
Noosa News18 hours agoProtest calls for shark net removal
-
General17 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News20 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
Business16 hours agoWhy this speculative ASX stock is jumping 6% today